Aktuellt
SENASTE
Redeye comments on Physitrack’s Q4 figures, which slightly missed our expectations on topline. On the positive side, ARR grew by 2% q/q accompanied by a positive cash flow. Following the report, we expect to make moderate adjustments to our near-term estimates and fair value range.
LÄS MER
